We are live on ! Find out more
WVE icon

Wave Life Sciences

190 hedge funds and large institutions have $1.05B invested in Wave Life Sciences in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 62 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $9.6M | Put options by funds: $4.79M

88% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 17

49% more capital inflows, than outflows

Capital inflows: $130M | Capital outflows: $87.1M

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

8% more funds holding

Funds holding: 176 → 190 (+14)

1.03% more ownership

Funds ownership: 89.31% → 90.35% (+1%)

2% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 62

Holders
190
Holders Change
+14
Holders Change %
+7.95%
% of All Funds
2.48%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
32
Increased
61
Reduced
62
Closed
17
Calls
$9.6​M
Puts
$4.79​M
Net Calls
+$4.85​M
Net Calls Change
+$1.79​M

WVE Hedge Fund Activity: Q3 2025 in Review

190 of the 7,665 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q3 2025, worth a combined $1.05B — up 17% from $903M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new WVE positions and 17 closed out — a net gain of 15 holders — while 61 added to existing stakes and 62 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $36.5M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.27M.

  • 190 institutional investors held Wave Life Sciences (WVE) as of Q3 2025, up from 176 in Q2 2025.
  • Funds reported $1.05B of Wave Life Sciences stock for Q3 2025, up 17% quarter-over-quarter.
  • 32 funds opened new Wave Life Sciences positions in Q3 2025 and 17 closed out, a net change of +15 holders.
  • The largest Wave Life Sciences buyer in Q3 2025 was Fidelity Investments, an estimated $36.5M added.
  • The largest Wave Life Sciences seller in Q3 2025 was T. Rowe Price Associates, an estimated $9.27M sold.

Based on aggregated 13F filings for Q3 2025.